Novacyt (XPAR:ALNOV) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALNOV Novacyt SA XPAR:ALNOV
34 GF Score
Price €0.51
GF Value €0.67
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Novacyt FFO per Share?

FFO per Share only applies to REITs.

XPAR:ALNOV
34GF Score
Novacyt SA XPAR:ALNOV
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Novacyt (XPAR:ALNOV) Overvalued in 2026?

Based on GuruFocus' analysis, Novacyt stock appears to be undervalued. The current stock price of €0.51 is trading 23.4% below its estimated GF Value™ of €0.67. GuruFocus considers Novacyt to be Modestly Undervalued.

Key valuation signals for XPAR:ALNOV:

  • FFO per Share:
  • GF Value™: €0.67 vs. price of €0.51 (23.4% below fair value)
  • GF Score™: 34/100 with 4 warning signs

No single metric tells the full story. See the XPAR:ALNOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novacyt Business Description

Other Exchanges NCYTl:UKNCYT:UKNYZ:Germany
Address 131 Boulevard Carnot, Le Vesinet, FRA, 78110
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments: Primer Design, Yourgene Health and Corporate. Majority of the revenue is generated from Yourgene Health segment. Geographically, the company operates in United Kingdom, France, Europe, America, Asia-Pacific, Middle East and Africa generating majority from Asia- pacific region.
34GF Score

Get the complete analysis for XPAR:ALNOV

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.51
Price
€0.67
GF Value